{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:03:08Z","timestamp":1791234188319,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,20]],"date-time":"2015-08-20T00:00:00Z","timestamp":1440028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,8,20]],"date-time":"2015-08-20T00:00:00Z","timestamp":1440028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1038\/gt.2015.75","type":"journal-article","created":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T14:52:37Z","timestamp":1437058357000},"page":"86-94","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Evaluation of helper-dependent canine adenovirus vectors in a 3D human CNS model"],"prefix":"10.1038","volume":"23","author":[{"given":"D","family":"Sim\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C J","family":"Peddie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Piersanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L M","family":"Collinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Saggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Schiavo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E J","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P M","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,20]]},"reference":[{"key":"BFgt201575_CR1","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/nm1113","volume":"10","author":"MS Forman","year":"2004","unstructured":"Forman MS, Trojanowski JQ, Lee VM . Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 2004; 10: 1055\u20131063.","journal-title":"Nat Med"},{"key":"BFgt201575_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4155\/tde.10.95","volume":"2","author":"A Ulusoy","year":"2011","unstructured":"Ulusoy A, Kirik D . Development of advanced therapies based on viral vector-mediated overexpression of therapeutic molecules and knockdown of disease-related genes for Parkinson\u2019s disease. Ther Deliv 2011; 2: 37\u201350.","journal-title":"Ther Deliv"},{"key":"BFgt201575_CR3","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.bbadis.2009.02.009","volume":"1792","author":"T Bj\u00f6rklund","year":"2009","unstructured":"Bj\u00f6rklund T, Kirik D . Scientific rationale for the development of gene therapy strategies for Parkinson\u2019s disease. Biochim Biophys Acta 2009; 1792: 703\u2013713.","journal-title":"Biochim Biophys Acta"},{"key":"BFgt201575_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.2741\/E607","volume":"5","author":"Y Gan","year":"2013","unstructured":"Gan Y, Jing Z, Stetler RA, Cao G . Gene delivery with viral vectors for cerebrovascular diseases. Front Biosci (Elite Ed) 2013; 5: 188\u2013203.","journal-title":"Front Biosci (Elite Ed)"},{"key":"BFgt201575_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.nbd.2011.09.014","volume":"48","author":"TB Lentz","year":"2012","unstructured":"Lentz TB, Gray SJ, Samulski RJ . Viral vectors for gene delivery to the central nervous system. Neurobiol Dis 2012; 48: 179\u2013188.","journal-title":"Neurobiol Dis"},{"key":"BFgt201575_CR6","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.pneurobio.2008.05.003","volume":"85","author":"A Toulouse","year":"2008","unstructured":"Toulouse A, Sullivan AM . Progress in Parkinson\u2019s disease-where do we stand? Prog Neurobiol 2008; 85: 376\u2013392.","journal-title":"Prog Neurobiol"},{"key":"BFgt201575_CR7","doi-asserted-by":"publisher","first-page":"517","DOI":"10.4155\/tde.10.50","volume":"1","author":"SJ Gray","year":"2010","unstructured":"Gray SJ, Woodard KT, Samulski RJ . Viral vectors and delivery strategies for CNS gene therapy. Ther Deliv 2010; 1: 517\u2013534.","journal-title":"Ther Deliv"},{"key":"BFgt201575_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2165\/11533740-000000000-00000","volume":"24","author":"LR Feng","year":"2010","unstructured":"Feng LR, Maguire-zeiss KA . Gene therapy in Parkinson\u2019s disease: rationale and current status. CNS Drugs 2010; 24: 177\u2013192.","journal-title":"CNS Drugs"},{"key":"BFgt201575_CR9","first-page":"204","volume":"9","author":"FP Manfredsson","year":"2010","unstructured":"Manfredsson FP, Mandel RJ . Development of gene therapy for neurological disorders. Discov Med 2010; 9: 204\u2013211.","journal-title":"Discov Med"},{"key":"BFgt201575_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1385\/MB:34:2:247","volume":"34","author":"M Perreau","year":"2006","unstructured":"Perreau M, Kremer EJ . The conundrum between immunological memory to adenovirus and their use as vectors in clinical gene therapy. Mol Biotechnol 2006; 34: 247\u2013256.","journal-title":"Mol Biotechnol"},{"key":"BFgt201575_CR11","doi-asserted-by":"publisher","first-page":"e1000442","DOI":"10.1371\/journal.ppat.1000442","volume":"5","author":"S Salinas","year":"2009","unstructured":"Salinas S, Bilsland LG, Henaff D, Weston AE, Keriel A, Schiavo G et al. CAR-associated vesicular transport of an adenovirus in motor neuron axons. PLoS Pathog 2009; 5: e1000442.","journal-title":"PLoS Pathog"},{"key":"BFgt201575_CR12","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1096\/fj.01-0321fje","volume":"15","author":"C Soudais","year":"2001","unstructured":"Soudais C, Laplace-Builhe C, Kissa K, Kremer EJ . Preferential transduction of neurons by canine adenovirus vectors and their efficient retrograde transport in vivo. FASEB J 2001; 15: 2283\u20132285.","journal-title":"FASEB J"},{"key":"BFgt201575_CR13","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.3390\/v2092134","volume":"2","author":"T Bru","year":"2010","unstructured":"Bru T, Salinas S, Kremer EJ . An update on canine adenovirus type 2 and its vectors. Viruses 2010; 2: 2134\u20132153.","journal-title":"Viruses"},{"key":"BFgt201575_CR14","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1096\/fj.03-0438fje","volume":"18","author":"C Soudais","year":"2004","unstructured":"Soudais C, Skander N, Kremer EJ . Long-term in vivo transduction of neurons throughout the rat CNS using novel helper-dependent CAV-2 vectors. FASEB J 2004; 18: 391\u2013393.","journal-title":"FASEB J"},{"key":"BFgt201575_CR15","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.bbadis.2009.08.014","volume":"1792","author":"B Sch\u00fcle","year":"2009","unstructured":"Sch\u00fcle B, Pera RAR, Langston JW . Can cellular models revolutionize drug discovery in Parkinson\u2019s disease? Biochim Biophys Acta 2009; 1792: 1043\u20131051.","journal-title":"Biochim Biophys Acta"},{"key":"BFgt201575_CR16","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrm2236","volume":"8","author":"F Pampaloni","year":"2007","unstructured":"Pampaloni F, Reynaud EG, Stelzer EHK . The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 2007; 8: 839\u2013845.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFgt201575_CR17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ymeth.2012.03.005","volume":"56","author":"C Brito","year":"2012","unstructured":"Brito C, Sim\u00e3o D, Costa I, Malpique R, Pereira CI, Fernandes P et al. 3D cultures of human neural progenitor cells: dopaminergic differentiation and genetic modification. Methods 2012; 56: 452\u2013460.","journal-title":"Methods"},{"key":"BFgt201575_CR18","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1089\/ten.tea.2014.0079","volume":"21","author":"D Sim\u00e3o","year":"2015","unstructured":"Sim\u00e3o D, Pinto C, Piersanti S, Weston A, Peddie CJ, Bastos AEP et al. Modeling Human Neural Functionality In Vitro: Three-Dimensional Culture for Dopaminergic Differentiation. Tissue Eng Part A 2015; 21: 654\u2013668.","journal-title":"Tissue Eng Part A"},{"key":"BFgt201575_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/gt.2012.52","volume":"20","author":"P Fernandes","year":"2013","unstructured":"Fernandes P, Peixoto C, Santiago VM, Kremer EJ, Coroadinha AS, Alves PM . Bioprocess development for canine adenovirus type 2 vectors. Gene Ther 2013; 20: 353\u2013360.","journal-title":"Gene Ther"},{"key":"BFgt201575_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/gt.2014.92","volume":"22","author":"P Fernandes","year":"2015","unstructured":"Fernandes P, Sim\u00e3o D, Guerreiro MR, Kremer EJ, Coroadinha AS, Alves PM . Impact of adenovirus life cycle progression on the generation of canine helper-dependent vectors. Gene Ther 2015; 22: 40\u201349.","journal-title":"Gene Ther"},{"key":"BFgt201575_CR21","doi-asserted-by":"publisher","first-page":"10639","DOI":"10.1128\/JVI.74.22.10639-10649.2000","volume":"74","author":"C Soudais","year":"2000","unstructured":"Soudais C, Boutin S, Hong SS, Chillon M, Danos O, Bergelson JM et al. Canine adenovirus type 2 attachment and internalization: coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway. J Virol 2000; 74: 10639\u201310649.","journal-title":"J Virol"},{"key":"BFgt201575_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1385\/ABAB:133:1:9","volume":"133","author":"SS Ghosh","year":"2006","unstructured":"Ghosh SS, Gopinath P, Ramesh A . Adenoviral vectors: a promising tool for gene therapy. Appl Biochem Biotechnol 2006; 133: 9\u201329.","journal-title":"Appl Biochem Biotechnol"},{"key":"BFgt201575_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2174\/1874467210801010013","volume":"1","author":"JK R\u00e4ty","year":"2008","unstructured":"R\u00e4ty JK, Pikkarainen JT, Wirth T, Yl\u00e4-Herttuala S . Gene therapy: the first approved gene-based medicines, molecular mechanisms and clinical indications. Curr Mol Pharmacol 2008; 1: 13\u201323.","journal-title":"Curr Mol Pharmacol"},{"key":"BFgt201575_CR24","doi-asserted-by":"crossref","unstructured":"Schwarz LA, Miyamichi K, Gao XJ, Beier KT, Weissbourd B, DeLoach KE et al. Viral-genetic tracing of the input -output organization of a central noradrenaline circuit. Nature 2015, e-pub ahead of print 1 July 2015; doi:10.1038\/nature14600.","DOI":"10.1038\/nature14600"},{"key":"BFgt201575_CR25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ymthe.2005.10.008","volume":"13","author":"RL Klein","year":"2006","unstructured":"Klein RL, Dayton RD, Leidenheimer NJ, Jansen K, Golde TE, Zweig RM . Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins. Mol Ther 2006; 13: 517\u2013527.","journal-title":"Mol Ther"},{"key":"BFgt201575_CR26","doi-asserted-by":"publisher","first-page":"e69808","DOI":"10.1371\/journal.pone.0069808","volume":"8","author":"S Piersanti","year":"2013","unstructured":"Piersanti S, Astrologo L, Licursi V, Costa R, Roncaglia E, Gennetier A et al. Differentiated neuroprogenitor cells incubated with human or canine adenovirus, or lentiviral vectors have distinct transcriptome profiles. PLoS One 2013; 8: e69808.","journal-title":"PLoS One"},{"key":"BFgt201575_CR27","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1128\/JVI.74.1.505-512.2000","volume":"74","author":"EJ Kremer","year":"2000","unstructured":"Kremer EJ, Boutin S, Chillon M, Danos O . Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer. J Virol 2000; 74: 505\u2013512.","journal-title":"J Virol"},{"key":"BFgt201575_CR28","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1128\/JVI.80.3.1487-1496.2006","volume":"80","author":"A Keriel","year":"2006","unstructured":"Keriel A, Ren\u00e9 C, Galer C, Zabner J, Kremer EJ . Canine adenovirus vectors for lung-directed gene transfer: efficacy, immune response, and duration of transgene expression using helper-dependent vectors canine adenovirus vectors for lung-directed gene transfer: efficacy, immune response, and durat. J Virol 2006; 80: 1487\u20131496.","journal-title":"J Virol"},{"key":"BFgt201575_CR29","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1126\/science.1226625","volume":"338","author":"K Doronin","year":"2012","unstructured":"Doronin K, Flatt JW, Di Paolo NC, Khare R, Kalyuzhniy O, Acchione M et al. Coagulation factor X activates innate immunity to human species C adenovirus. Science 2012; 338: 795\u2013798.","journal-title":"Science"},{"key":"BFgt201575_CR30","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1128\/JVI.03576-14","volume":"89","author":"K Eichholz","year":"2015","unstructured":"Eichholz K, Mennechet FJD, Kremer EJ . Human coagulation factor X-adenovirus type 5 complexes poorly stimulate an innate immune response in human mononuclear phagocytes. J Virol 2015; 89: 2884\u20132891.","journal-title":"J Virol"},{"key":"BFgt201575_CR31","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1006\/mthe.2001.0263","volume":"3","author":"C Soudais","year":"2001","unstructured":"Soudais C, Boutin S, Kremer EJ . Characterization of cis-acting sequences involved in canine adenovirus packaging. Mol Ther 2001; 3: 631\u2013640.","journal-title":"Mol Ther"},{"key":"BFgt201575_CR32","doi-asserted-by":"publisher","first-page":"33704","DOI":"10.1074\/jbc.M605316200","volume":"281","author":"E Seiradake","year":"2006","unstructured":"Seiradake E, Lortat-Jacob H, Billet O, Kremer EJ, Cusack S . Structural and mutational analysis of human Ad37 and canine adenovirus 2 fiber heads in complex with the D1 domain of coxsackie and adenovirus receptor. J Biol Chem 2006; 281: 33704\u201333716.","journal-title":"J Biol Chem"},{"key":"BFgt201575_CR33","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1074\/jbc.M113.518365","volume":"289","author":"S Salinas","year":"2014","unstructured":"Salinas S, Zussy C, Loustalot F, Henaff D, Menendez G, Morton PE et al. Disruption of the coxsackievirus and adenovirus receptor-homodimeric interaction triggers lipid microdomain- and dynamin-dependent endocytosis and lysosomal targeting. J Biol Chem 2014; 289: 680\u2013695.","journal-title":"J Biol Chem"},{"key":"BFgt201575_CR34","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/sj.gt.3302538","volume":"12","author":"D Huang","year":"2005","unstructured":"Huang D, Desbois A, Hou ST . A novel adenoviral vector which mediates hypoxia-inducible gene expression selectively in neurons. Gene Ther 2005; 12: 1369\u20131376.","journal-title":"Gene Ther"},{"key":"BFgt201575_CR35","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/sj.gt.3302779","volume":"13","author":"K Namikawa","year":"2006","unstructured":"Namikawa K, Murakami K, Okamoto T, Okado H, Kiyama H . A newly modified SCG10 promoter and Cre\/loxP-mediated gene amplification system achieve highly specific neuronal expression in animal brains. Gene Ther 2006; 13: 1244\u20131250.","journal-title":"Gene Ther"},{"key":"BFgt201575_CR36","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1006\/exnr.2001.7706","volume":"170","author":"A Storch","year":"2001","unstructured":"Storch A, Paul G, Csete M, Boehm BO, Carvey PM, Kupsch et al. Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Exp Neurol 2001; 170: 317\u2013325.","journal-title":"Exp Neurol"},{"key":"BFgt201575_CR37","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1089\/104303400750001417","volume":"11","author":"G Schiedner","year":"2000","unstructured":"Schiedner G, Hertel S, Kochanek S . Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production. Hum Gene Ther 2000; 11: 2105\u20132116.","journal-title":"Hum Gene Ther"},{"key":"BFgt201575_CR38","doi-asserted-by":"publisher","first-page":"e60342","DOI":"10.1371\/journal.pone.0060342","volume":"8","author":"P Fernandes","year":"2013","unstructured":"Fernandes P, Santiago VM, Rodrigues AF, Tom\u00e1s H, Kremer EJ, Alves PM et al. Impact of E1 and Cre on adenovirus vector amplification: developing MDCK CAV-2-E1 and E1-Cre transcomplementing cell lines. PLoS One 2013; 8: e60342.","journal-title":"PLoS One"},{"key":"BFgt201575_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/btpr.64","volume":"25","author":"TB Ferreira","year":"2009","unstructured":"Ferreira TB, Perdig\u00e3o R, Silva AC, Zhang C, Aunins JG, Carrondo MJT et al. 293 cell cycle synchronisation adenovirus vector production. Biotechnol Prog 2009; 25: 235\u2013243.","journal-title":"Biotechnol Prog"},{"key":"BFgt201575_CR40","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/biot.201400765","volume":"10","author":"AC Silva","year":"2015","unstructured":"Silva AC, Sim\u00e3o D, K\u00fcppers C, Lucas T, Sousa MFQ, Cruz P et al. Human amniocyte-derived cells are a promising cell host for adenoviral vector production under serum-free conditions. Biotechnol J 2015; 10: 760\u2013771.","journal-title":"Biotechnol J"},{"key":"BFgt201575_CR41","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/(SICI)1097-0290(19961105)52:3<429::AID-BIT9>3.0.CO;2-M","volume":"52","author":"P Alves","year":"1996","unstructured":"Alves P, Moreira J, Rodrigues J, Aunins J, Carrondo M . Two-dimensional versus three-dimensional culture systems: Effects on growth and productivity of BHK cells. Biotechnol Bioeng 1996; 52: 429\u2013432.","journal-title":"Biotechnol Bioeng"},{"key":"BFgt201575_CR42","doi-asserted-by":"publisher","first-page":"e23212","DOI":"10.1371\/journal.pone.0023212","volume":"6","author":"M Serra","year":"2011","unstructured":"Serra M, Correia C, Malpique R, Brito C, Jensen J, Bjorquist P et al. Microencapsulation technology: a powerful tool for integrating expansion and cryopreservation of human embryonic stem cells. PLoS One 2011; 6: e23212.","journal-title":"PLoS One"},{"key":"BFgt201575_CR43","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T et al. Fiji: an open-source platform for biological-image analysis. Nat Methods 2012; 9: 676\u2013682.","journal-title":"Nat Methods"},{"key":"BFgt201575_CR44","unstructured":"Deerinck TJ, Bushong EA, Thor A, Ellisman MH . NCMIR methods for 3D EM: a new protocol for preparation of biological specimens for serial block face scanning electron microscopy 2010, http:\/\/ncmir.ucsd.edu\/sbfsem-protocol.pdf."},{"key":"BFgt201575_CR45","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402\u2013408.","journal-title":"Methods"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201575.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201575","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201575.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T13:08:53Z","timestamp":1648559333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,20]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["BFgt201575"],"URL":"https:\/\/doi.org\/10.1038\/gt.2015.75","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,20]]},"assertion":[{"value":"7 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}